i
Pneumococcal polysaccharide 15-valent conjugate vaccine (V114, VAXNEUVANCE) : pediatric clinical development program
-
February 24, 2022
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +